Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNSS
DateTimeSourceHeadlineSymbolCompany
11/21/20175:28PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/13/20174:37PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/07/20175:20PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/07/20174:54PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/07/20174:04PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/06/20174:50PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/02/20174:34PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/02/20177:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/02/20177:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Third Quarter 2017 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
10/31/20174:21PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/30/20177:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/27/20177:00AMGlobeNewswire Inc.Sunesis to Host Conference Call on November 2nd to Discuss Third Quarter 2017 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
10/26/20174:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/26/20171:15PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/26/20171:13PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/25/20178:54AMGlobeNewswire Inc.Sunesis Announces Pricing of $20 Million Offering of SecuritiesNASDAQ:SNSSSunesis Pharmaceuticals Inc
10/24/20175:29PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/24/20175:28PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/24/20174:05PMGlobeNewswire Inc.Sunesis Announces Proposed Public Offering of Common Stock, Preferred Stock and WarrantsNASDAQ:SNSSSunesis Pharmaceuticals Inc
08/31/20177:00AMGlobeNewswire Inc.Sunesis to Present at Upcoming Investor ConferencesNASDAQ:SNSSSunesis Pharmaceuticals Inc
08/28/20174:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/27/20174:03PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/27/20177:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/27/20177:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Second Quarter 2017 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/24/20177:00AMGlobeNewswire Inc.Sunesis to Host Conference Call on July 27th to Discuss Second Quarter 2017 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/18/20174:05PMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Study Evaluating Oral Non-Covalent BTK-inhibitor SNS-062 ...NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/12/20175:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/12/20174:08PMEdgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/20172:13PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/30/20175:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNSS